tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hypoglycemia D007003 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Biliary Fistula D001658 13 associated lipids
Urticaria D014581 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Glucose Intolerance D018149 13 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Uveitis D014605 14 associated lipids
Alopecia D000505 14 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Stomatitis D013280 14 associated lipids
Vasculitis D014657 14 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hemorrhage D006470 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Neutropenia D009503 15 associated lipids
Tremor D014202 15 associated lipids
Encephalitis D004660 15 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
Demyelinating Diseases D003711 15 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Testicular Diseases D013733 15 associated lipids
Choline Deficiency D002796 16 associated lipids
Cholelithiasis D002769 16 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Vascular Diseases D014652 16 associated lipids
Ulcer D014456 16 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Dermatomycoses D003881 17 associated lipids
Brain Infarction D020520 17 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Down Syndrome D004314 18 associated lipids
Albuminuria D000419 18 associated lipids
Mycoses D009181 18 associated lipids
Lymphoma D008223 18 associated lipids
Ischemia D007511 18 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Peptic Ulcer D010437 19 associated lipids
Pregnancy Complications D011248 19 associated lipids
Cough D003371 19 associated lipids
Nephritis D009393 19 associated lipids
Hypothermia D007035 19 associated lipids
HIV Infections D015658 20 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Lerut JP et al. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. 2014 Ann. Surg. pmid:25379858
Colombani PM et al. Liver transplantation in infants younger than 1 year of age. 1996 Ann. Surg. pmid:8645039
Stratta RJ et al. Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction. 1999 Ann. Surg. pmid:10235529
Shapiro R et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. 2003 Ann. Surg. pmid:14530723
Ozawa K et al. An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. 1992 Ann. Surg. pmid:1280074
Vivarelli M et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 2008 Ann. Surg. pmid:18948815
Abu-Elmagd K et al. Clinical intestinal transplantation: a decade of experience at a single center. 2001 Ann. Surg. pmid:11524593
Todo S et al. Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. 1994 Ann. Surg. pmid:7522431
Schneeberger S et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. 2013 Ann. Surg. pmid:23001085
Sho M et al. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. 2002 Ann. Surg. pmid:12409674
Gerster JC et al. Gout in liver transplant patients receiving tacrolimus. 2004 Ann. Rheum. Dis. pmid:15194597
Igarashi T et al. Central nervous system toxicity related to FK506 in patients with Behçet's disease. 1994 Ann. Rheum. Dis. pmid:7517134
Villaverde V et al. Leg bone pain syndrome in a kidney transplant patient treated with tacrolimus (FK506) 1999 Ann. Rheum. Dis. pmid:10577370
Duddridge M and Powell RJ Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. 1997 Ann. Rheum. Dis. pmid:9462174
Lightman S et al. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. 2015 Ann. Rheum. Dis. pmid:25269831
Lampropoulos CE and D' Cruz DP Topical tacrolimus treatment in a patient with dermatomyositis. 2005 Ann. Rheum. Dis. pmid:16100347
Mok CC et al. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. 2016 Ann. Rheum. Dis. pmid:25550339
Nelson M et al. Direct revascularization is superior for rat parathyroid allotransplantation with FK506. 2005 Ann. Otol. Rhinol. Laryngol. pmid:15825570
Paterson DL et al. Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? 1997 Ann. Neurol. pmid:9266742
Caprariello AV et al. Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. 2012 Ann. Neurol. pmid:23034912
Keswani SC et al. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. 2003 Ann. Neurol. pmid:12509848
Dawson TM Immunosuppressants, immunophilins, and the nervous system. 1996 Ann. Neurol. pmid:8871573
Small SL et al. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506) 1996 Ann. Neurol. pmid:8871576
Roberts WK et al. A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. 2015 Ann. Neurol. pmid:26224283
Wijdicks EF et al. FK506-induced neurotoxicity in liver transplantation. 1994 Ann. Neurol. pmid:7512320
Sun L et al. Cellular and molecular consequences of calcineurin A alpha gene deletion. 2007 Ann. N. Y. Acad. Sci. pmid:17872390
Shipston MJ et al. Glucocorticoid negative feedback in pituitary corticotropes. Pivotal role for calcineurin inhibition of adenylyl cyclase. 1994 Ann. N. Y. Acad. Sci. pmid:7529975
Iwanaga Y et al. Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant. 2006 Ann. N. Y. Acad. Sci. pmid:17130575
Xu L et al. Potential for pharmacology of ryanodine receptor/calcium release channels. 1998 Ann. N. Y. Acad. Sci. pmid:10603942
Bers DM et al. Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. 1998 Ann. N. Y. Acad. Sci. pmid:10603944
Engelbrecht ME et al. The effect of immunosuppressants on human leukocyte NADPH oxidase. 1994 Ann. N. Y. Acad. Sci. pmid:7518204
Zuany-Amorim C et al. Modulation by rm interferon-gamma and CD4+ T-lymphocytes of allergic eosinophil accumulation in the mice peritoneal cavity. 1994 Ann. N. Y. Acad. Sci. pmid:7518212
Nagai H et al. The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. 1996 Ann. N. Y. Acad. Sci. pmid:8906215
Clipstone NA and Crabtree GR Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. 1993 Ann. N. Y. Acad. Sci. pmid:7509131
Takahara S Efficacy of FK506 in renal transplantation. 1993 Ann. N. Y. Acad. Sci. pmid:7509132
Thomson AW et al. Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy. 1993 Ann. N. Y. Acad. Sci. pmid:7509133
Lemster B et al. FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions. 1993 Ann. N. Y. Acad. Sci. pmid:7509134
Tamura K et al. Inhibitory effect of FK 506 on autoimmune thyroid disease in the PVG rat. 1993 Ann. N. Y. Acad. Sci. pmid:7509135
Ochiai T et al. Combination of immunosuppressive drugs for organ transplantation. 1993 Ann. N. Y. Acad. Sci. pmid:7509136
Wiederrecht G et al. The mechanism of action of FK-506 and cyclosporin A. 1993 Ann. N. Y. Acad. Sci. pmid:7509138
Lee RK and Wurtman RJ Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors. 2000 Ann. N. Y. Acad. Sci. pmid:11193162
Christensen BG FK-506: its role in immunosuppression. 1993 Ann. N. Y. Acad. Sci. pmid:7689803
Kino T and Goto T Discovery of FK-506 and update. 1993 Ann. N. Y. Acad. Sci. pmid:7689804
Parsons WH et al. FK-506--a novel immunosuppressant. 1993 Ann. N. Y. Acad. Sci. pmid:7689805
Zenke G et al. Molecular mechanisms of immunosuppression by cyclosporins. 1993 Ann. N. Y. Acad. Sci. pmid:7689806
Clardy J Structural studies of complexed FK-506 binding protein. 1993 Ann. N. Y. Acad. Sci. pmid:7689808
Starzl TE et al. Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment. 1993 Ann. N. Y. Acad. Sci. pmid:7689809
Reem GH et al. FK-506 inhibits the IL-2-independent induction of the activation antigen CD 69. 1993 Ann. N. Y. Acad. Sci. pmid:7689811
Mollison KW et al. Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation. 1993 Ann. N. Y. Acad. Sci. pmid:7689812
Ponseti JM et al. Tacrolimus for myasthenia gravis: a clinical study of 212 patients. 2008 Ann. N. Y. Acad. Sci. pmid:18096852
Sugden PH Signalling pathways in cardiac myocyte hypertrophy. 2001 Ann. Med. pmid:11817656
Donners MM et al. Inflammation and restenosis: implications for therapy. 2003 Ann. Med. pmid:14649334
Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis. 2015 Ann. Intern. Med. pmid:25383607
Liu Z et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. 2015 Ann. Intern. Med. pmid:25383558
Kawai T et al. FK506-induced autoimmune diabetes. 2000 Ann. Intern. Med. pmid:10733461
D'Incà R et al. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine. 1998 Ann. Intern. Med. pmid:9556483
Cotton D Celebrating the ACP centennial: from the Annals archive. 2015 Ann. Intern. Med. pmid:25560715
Abu-Elmagd K et al. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). 1993 Ann. Intern. Med. pmid:7689802
Yano S et al. Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation. 2015 Ann. Hematol. pmid:25325985
Mori A et al. Fatal cerebral hemorrhage associated with cyclosporin-A/FK506-related encephalopathy after allogeneic bone marrow transplantation. 2000 Ann. Hematol. pmid:11100753
Nasu R et al. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases. 2014 Ann. Hematol. pmid:24590535
Mizuno H et al. Extranodal NK/T cell lymphoma in a living donor liver transplant recipient. 2017 Ann. Hematol. pmid:28280996
Imataki O et al. Reversible cerebral vasoconstriction syndrome resulted in cerebral infarction after allogeneic stem cell transplantation: a case report. 2014 Ann. Hematol. pmid:24061786
Moiseev IS et al. Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis. 2017 Ann. Hematol. pmid:28343273
Uni M et al. Successful allogeneic stem cell transplantation for Lennert lymphoma. 2013 Ann. Hematol. pmid:23224245
Watanabe M et al. Successful treatment of calcineurin inhibitor-induced pain syndrome with acute graft versus host disease by switching calcineurin inhibitors followed by pregabalin. 2017 Ann. Hematol. pmid:28508935
Zhu X et al. Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells. 1995 Ann. Hematol. pmid:8534762
Cannon RD et al. Clinical efficacy of the Abbott Tacrolimus II assay for the IMx. 1999 Oct-Dec Ann. Clin. Lab. Sci. pmid:10528829
Dasgupta A et al. Analytical Performance Evaluation of a New Cobas Tacrolimus Assay on Cobas e411 Analyzer: Comparison of Values Obtained by the CMIA Tacrolimus Assay and a Liquid Chromatography Combined with Tandem Mass Spectrometric Method. 2016 Ann. Clin. Lab. Sci. pmid:27098629
Hinchliffe E et al. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots. 2014 Ann. Clin. Biochem. pmid:23939194
Stephen DW et al. Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650. 2003 Ann. Clin. Biochem. pmid:14629812
Keevil BG et al. Liquid chromatography-mass spectrometry measurement of tacrolimus in finger-prick samples compared with venous whole blood samples. 2009 Ann. Clin. Biochem. pmid:19151171
Keevil BG et al. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry. 2002 Ann. Clin. Biochem. pmid:12227855
Trull AK Therapeutic monitoring of tacrolimus. 1998 Ann. Clin. Biochem. pmid:9547889
Yargui L and Berhoune A [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer]. 2008 Nov-Dec Ann. Biol. Clin. (Paris) pmid:19091665
Kanchongkittiphon W et al. Child with atopic dermatitis. 2015 Ann. Allergy Asthma Immunol. pmid:25528736
Lin SJ et al. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells. 2005 Ann. Allergy Asthma Immunol. pmid:16400900
Matsuo N et al. Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues. 2001 Ann. Allergy Asthma Immunol. pmid:11428741
Fonacier L et al. The black box warning for topical calcineurin inhibitors: looking outside the box. 2006 Ann. Allergy Asthma Immunol. pmid:16892793
Talreja N et al. Successful desensitization to agalsidase beta after anaphylaxis. 2014 Ann. Allergy Asthma Immunol. pmid:24331397
Leonardi S et al. Intense tacrolimus ointment therapy in children with serious atopic eczema dermatitis syndrome. 2009 Ann. Allergy Asthma Immunol. pmid:19663137
Knight AK et al. Alcohol-induced rash caused by topical tacrolimus. 2005 Ann. Allergy Asthma Immunol. pmid:16200821
Amrol D et al. Topical pimecrolimus in the treatment of human allergic contact dermatitis. 2003 Ann. Allergy Asthma Immunol. pmid:14700441
Hung SH et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. 2007 Ann. Allergy Asthma Immunol. pmid:17225720
Graham F et al. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies. 2015 Ann. Allergy Asthma Immunol. pmid:26094803
Letko E et al. Tacrolimus (FK 506). 1999 Ann. Allergy Asthma Immunol. pmid:10507260
Lim SM and White DJ The pharmacology of immunosuppression. 1991 Ann. Acad. Med. Singap. pmid:1709344
Woo KT Current therapeutic strategies in glomerulonephritis. 1999 Ann. Acad. Med. Singap. pmid:10497681
McWhinnie DL and Morris PJ Combination drug therapies for immunosuppression in transplantation. 1991 Ann. Acad. Med. Singap. pmid:1724724
Calmus Y [Rejection of a liver allograft. Diagnosis and treatment]. 1994 Ann Radiol (Paris) pmid:7527621
Cole O et al. The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model. 2001 Ann R Coll Surg Engl pmid:11518369
Chu FC et al. Oral health status, oral microflora, and non-surgical periodontal treatment of renal transplant patients receiving cyclosporin A and FK506. 2000 Ann R Australas Coll Dent Surg pmid:11709958
Nezami BG et al. Pharmacologic preconditioning of random-pattern skin flap in rats using local cyclosporine and FK-506: interaction with nitric oxide system. 2007 Ann Plast Surg pmid:17901737
Jensen JN et al. Effect of FK506 on peripheral nerve regeneration through long grafts in inbred swine. 2005 Ann Plast Surg pmid:15785285
Diaz LM et al. The role of topically administered FK506 (tacrolimus) at the time of facial nerve repair using entubulation neurorrhaphy in a rabbit model. 2004 Ann Plast Surg pmid:15084888
Ueno T et al. Evaluation of osteogenic/chondrogenic cellular proliferation and differentiation in the xenogeneic periosteal graft. 2002 Ann Plast Surg pmid:11981197
Büttemeyer R et al. Peripheral nerve allograft transplantation with FK506: functional, histological, and immunological results before and after discontinuation of immunosuppression. 1995 Ann Plast Surg pmid:8585683
Cetinkale O et al. Involvement of neutrophils in ischemic injury. I. Biochemical and histopathological investigation of the effect of FK506 on dorsal skin flaps in rats. 1997 Ann Plast Surg pmid:9374148
Terzis JK and Konofaos P Low-dose FK506 after contralateral C7 transfer to the musculocutaneous nerve using two different tubes: a study in rats. 2010 Ann Plast Surg pmid:20395813
Seifeldin RA et al. Nifedipine interaction with tacrolimus in liver transplant recipients. 1997 Ann Pharmacother pmid:9161650